NOT KNOWN DETAILS ABOUT DIABETES LAB TESTS

Novel therapies, which include GLP-1 receptor agonists and SGLT2 inhibitors, are safer considering the fact that they do not cause hypoglycemia, are weight neutral or end in weight loss and blood pressure and impact vascular complications favorably.Men and women with non-diabetic hyperglycaemia are at increased risk of producing type two diabetes,